Related references
Note: Only part of the references are listed.Insights into four helical proteins folding via self-guided Langevin dynamics simulation
Shuheng Dong et al.
MOLECULAR PHYSICS (2021)
Inhibition mechanism and hot-spot prediction of nine potential drugs for SARS-CoV-2 Mpro by large-scale molecular dynamic simulations combined with accurate binding free energy calculations
Song Luo et al.
NANOSCALE (2021)
An accurate free energy estimator: based on MM/PBSA combined with interaction entropy for protein-ligand binding affinity
Kaifang Huang et al.
NANOSCALE (2020)
Study on the Amyloid Aβ42 with Accelerated Molecular Dynamics Simulations
Kai-Fang Huang et al.
COMMUNICATIONS IN THEORETICAL PHYSICS (2019)
What Contributes to Serotonin-Norepinephrine Reuptake Inhibitors' Dual-Targeting Mechanism? The Key Role of Transmembrane Domain 6 in Human Serotonin and Norepinephrine Transporters Revealed by Molecular Dynamics Simulation
Weiwei Xue et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Computational Alanine Scanning with Interaction Entropy for Protein-Ligand Binding Free Energies
Xiao Liu et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2018)
Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity
Ryan S. Soderquist et al.
NATURE COMMUNICATIONS (2018)
The impact of interior dielectric constant and entropic change on HIV-1 complex binding free energy prediction
Yuchen Li et al.
STRUCTURAL DYNAMICS-US (2018)
Virtual screening of Piperine analogs as Survivin inhibitors and their molecular interaction analysis by using consensus docking, MD simulation, MMPB/GBSA and alanine scanning techniques
Elham Sattarinezhad et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2017)
Interaction Entropy for Computational Alanine Scanning
Yuna Yan et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
Akane Inoue-Yamauchi et al.
NATURE COMMUNICATIONS (2017)
Interaction Entropy: A New Paradigm for Highly Efficient and Reliable Computation of Protein-Ligand Binding Free Energy
Lili Duan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Towards the next generation of dual Bcl-2/Bcl-xL inhibitors
Jeffrey G. Varnes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Free Energy Calculations by the Molecular Mechanics Poisson-Boltzmann Surface Area Method
Nadine Homeyer et al.
MOLECULAR INFORMATICS (2012)
Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
Bonsu Ku et al.
CELL RESEARCH (2011)
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab
Farrukh T. Awan et al.
BLOOD (2009)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Comparison of multiple amber force fields and development of improved protein backbone parameters
Viktor Hornak et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
Marina Konopleva et al.
CANCER CELL (2006)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Apoptosis in neurodegenerative disorders
MP Mattson
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)
Share Paper
